Navigation Links
A Canada-wide technology platform for mapping the human interactome
Date:6/23/2009

Montral, June 23, 2009 On June 18, the Canada Foundation for Innovation (CFI) announced the award of $9.16 million for the creation of a national technology platform aimed at mapping the human interactome. This national platform, headed by Dr. Benoit Coulombe from the Institut de recherches cliniques de Montral (IRCM), will not only provide Canadian researchers with new state-of-the-art equipment in proteomics, functional genomics and bioinformatics, but also bring together integrated infrastructure for deciphering the human interactome an expertise that, until now, has been spread in 12 universities across Canada.

Sequencing the human genome has revolutionized biomedical research. One of the major challenges that scientists throughout the world are facing in the post-genome era is the mapping of the interactome, which can be defined as the complete set of interaction networks underlying the functioning of our cells. The creation of a nation-wide platform will allow Canadian scientists to position themselves favorably in interactome research. In fact, a group of Canadian researchers led by Dr. Coulombe is currently working with American and European colleagues on the creation of an international project, the International Interactome Initiative (I3), aimed at developing new technologies and expertise to elucidate the interactome.

"Canada has now a powerful tool that will allow its scientists to continue to take the lead in international research on the human interactome," mentioned Dr. Coulombe. "Thanks to this $22.9 million investment from the CFI and the other partners in this project, we will not only be able to gather detailed data allowing us to understand the interactome's dynamic organization, but also combine the areas of expertise of some of our best scientists through a very promising multidisciplinary project for our country and our respective provinces and institutions." According to Dr. Coulombe, understanding the interactome's o
'/>"/>

Contact: Benoit Coulombe
Benoit.Coulombe@ircm.qc.ca
514-987-5662
Institut de recherches cliniques de Montreal
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. Study shows Chronix technology using serum DNA can identify early presence of disease
2. Parascript Signature Verification Technology Used by Moscow Law Firm to Detect Signature Fraud in $160,000 Debt Collection Case
3. Technology guide: Principles -- applications -- trends
4. Continuous glucose monitoring technology -- special issue of Diabetes Technology and Therapeutics
5. Triage technology with a Star Trek twist
6. Demonstration Features Commercial Technology for Combating Terrorism
7. Uniloc Unveils Industry-First Authentication Technology for Comprehensive Protection of Critical Infrastructure
8. Uniloc Unveils Industry-First Authentication Technology for Comprehensive Protection of Critical Infrastructure
9. Demonstration Features Commercial Technology for Combating Terrorism
10. University awarded £1.7M to develop nanotechnology for use in health care
11. Nanotechnology holds promise for STD drug delivery

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...vember 26, 2009) Whitehead researchers have devel...to pinpoint specific genes and proteins used by pa... In most human cell cultures genes are present in... from the mother. Gene inactivation by mutation is...activated, the second copy usually remains active ...
(Date:11/25/2009)...roduced in the stomach, may be used to boost resis...disease, Yale School of Medicine researchers repor...ournal of Neuroscience . , Parkinson,s disease i...an area of the midbrain known as the substantia ni... Reduced production of dopamine in late-stage Par...
(Date:11/25/2009)...R 25, 2009 Soil is the linchpin of the environmen...et. Despite that, many students see soil as "just ...oil science educators are challenged with the task...critical importance of soil in the environment. ,...th science teachers at University of Nebraska-Linc...
Breaking Biology News(10 mins):Knockouts in human cells point to pathogenic targets 2Hormone ghrelin can boost resistance to Parkinson's disease 2It's not just dirt! 2New Study Shows Coaching to Patient Activation Levels Improves Disease Management Outcomes 48402 1New Study Shows Coaching to Patient Activation Levels Improves Disease Management Outcomes 48402 2New Study Shows Coaching to Patient Activation Levels Improves Disease Management Outcomes 48402 3New Study Shows Coaching to Patient Activation Levels Improves Disease Management Outcomes 48402 4New Study Shows Coaching to Patient Activation Levels Improves Disease Management Outcomes 48402 5New Shape HF 26amp 3B 238482 3B Cardiopulmonary Testing System to be on Display at 2009 American Association of Heart Failure Nurses Annual Meeting 48399 1New Shape HF 26amp 3B 238482 3B Cardiopulmonary Testing System to be on Display at 2009 American Association of Heart Failure Nurses Annual Meeting 48399 2New Shape HF 26amp 3B 238482 3B Cardiopulmonary Testing System to be on Display at 2009 American Association of Heart Failure Nurses Annual Meeting 48399 3Overview of Pixantrone Phase III Clinical Data Presentation at American Society of Clinical Oncology 2009 Annual Meeting Now Available at Clinical Car 4580 1
... be exhausting. When fruit flies mate, the females...s when an immune reaction starts. This is shown in...ng in the scientific publication, Journal of Evol...avioral studies and genomic technology, so-called ... show how fruit fly females are affected by mating...
...ase is available in French . , Montreal, Febru... life has been resolved. According to a study publ...ntral scientists have proposed a new theory for ho...aged to self-assemble as a critical step in the ge... is a complex structure it features a clear hierar...
...Observatory of Singapore (EOS) which aspires to be... addressing several of civilisation,s most serious...namis, volcanic eruptions and climate change aims...ocus on Southeast Asia, that could potentially sav...highly anticipated first Research Centre of Excell...
Other Biology News:Life secret exposed: Scientists unlock mystery of molecular machine 2The Earth Observatory of Singapore devoted to the study of earth sciences officially opens 2The Earth Observatory of Singapore devoted to the study of earth sciences officially opens 3
(Date:11/24/2009)...nt bank KTA Capital,s client Neuren Pharmaceutical...le note private placement with a U.S. institutiona...KTA Capital as Neuren,s exclusive placement agent ...PRWEB) November 23, 2009 -- The independent New Yo...ital") has announced that its client Neuren P...
(Date:11/24/2009)...irstCall/ -- Sigma-Aldrich Corporation (Nasdaq: S...nce on Tuesday, December 1st at 1:45 PM GMT in Lon... via live audio broadcast over the Internet availa...com/ . Users can click the "Webcast" icon to acc...gma-Aldrich is a leading Life Science and High Tec...
(Date:11/24/2009)...ewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NG...oping and commercializing novel pain management th...sident and Chief Executive Officer, is scheduled t...Care Conference, to be held December 1-2, 2009 at ...,, Mr. DiTonno and Stephen Ghiglieri, Chief Fin...
(Date:11/24/2009)... been met for patients with advanced-stage, or ...Nov. 24 /PRNewswire-FirstCall/ - AEterna Zentaris ... global biopharmaceutical company focused on endoc...e efficacy data from a Phase 2 study with its targ...ly AN-152), in patients with advanced or recurrent...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
...American Association for Cancer Research ...il 15 ADVENTRX Pharmaceuticals,Inc. (Amex: ANX )...from its,registrational bioequivalence clinical st...American Association for Cancer Research (AACR),An...harmacokinetic,equivalence observed between an emu...
...Trust, Inc.,(NYSE: BMR ) today announced that Mar...ncurrently with the company,s annual meeting of st..., the Ernest W. Hahn Professor of Real Estate Fina...enter for Real Estate at the,University of San Die...rectors since its initial public offering in 2004,...
...ting Late-Breaking Clinical Trials ...IEGO, April 14 ,Medivation, Inc. (Nasdaq: MDVN ) ...2 clinical trial showed that the Company,s novel a... reduce serum levels of prostate specific,antigen ...anded dose group,tested after three months of trea...
Other Biology Technology:ANX-530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in a Registrational Bioequivalence Clinical Study 2ANX-530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in a Registrational Bioequivalence Clinical Study 3ANX-530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in a Registrational Bioequivalence Clinical Study 4ANX-530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in a Registrational Bioequivalence Clinical Study 5BioMed Realty Trust Announces Retirement of Mark Riedy From Its Board of Directors 2BioMed Realty Trust Announces Retirement of Mark Riedy From Its Board of Directors 3Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients 2Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients 3
...ip arrays have been developed for affinity capture... ProteinChip chemical surfaces allow differential ...hemical properties. Each chip has eight different ...d the chips are color-coded with a unique hydropho...
Thermal Printer, 120 V from Bio-Rad
...Assay with FAM-Labeled Substrate (green fluorescen...e serine protease activation • No lysing, fix...its utilize cell-permeable, fluorescently labeled ... chymotrypsin-like activity in whole living cells....
...ay systems, known as ChemiArrayTM Mouse Cytokine A...ith current methodologies. Besides the ability to ...nt a more accurate reflection of active cytokine l... and no amplification step is needed. Furthermore,...
Biology Products: